Question 1

What is the catalog number for Recombinant Burkholderia mallei NADH-quinone oxidoreductase subunit A (nuoA), partial?

Accepted Answer

The catalog number for Recombinant Burkholderia mallei NADH-quinone oxidoreductase subunit A (nuoA), partial is MBS7063737.

Question 2

What sizes are available for Recombinant Burkholderia mallei NADH-quinone oxidoreductase subunit A (nuoA), partial?

Accepted Answer

Recombinant Burkholderia mallei NADH-quinone oxidoreductase subunit A (nuoA), partial is available in the following size(s): Inquire.

Question 3

Is Recombinant Burkholderia mallei NADH-quinone oxidoreductase subunit A (nuoA), partial in stock?

Accepted Answer

Recombinant Burkholderia mallei NADH-quinone oxidoreductase subunit A (nuoA), partial is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 5

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

Question 6

Can this product be used in multiplex assays?

Accepted Answer

Multiplex compatibility depends on the specific product and detection panel. Contact our technical support team with details of your multiplex system for guidance before ordering.

Recombinant Burkholderia mallei NADH-quinone oxidoreductase subunit A (nuoA), partial

Product Specifications

CAS Number

Gene Name

Storage Conditions

Other Gene Names

Short Name

Other Product Names

NCBI GI Number

NCBI Accession Number

NCBI GB Accession Number

Uniprot Accession Number

Frequently Asked Questions

Explore Other Products

CD45 / LCA (135-4C5), 1mg/mL

Anti-PLA2G4A Antibody (Center)

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2741), CF647 conjugate, 0.1mg/mL

MDM2 (MDM2/2414), CF640R conjugate, 0.1mg/mL

Smooth Muscle Actin (1A4), CF405S conjugate, 0.1mg/mL

USP39 Recombinant Rabbit Monoclonal Antibody [JE61-02]